Decision and Details
Registration in Mexico of a use patent for a treatment for cartilage diseases
The purpose is to expand the indications for Redasemtide, which is currently under development. The granting of the patent will preserve the possibility of developing treatments for cartilage diseases based on Redasemtide in Mexico.
This matter will have no impact on full-year results for the fiscal year ending July 2026.
| Item | Details |
|---|---|
| Matter Covered | Registration in Mexico of a use patent for a treatment for cartilage diseases |
| Implementation Date | Patent registration (publication) scheduled. Specific date: Not disclosed |
| Quantity / scale | Application number: MX/a/2021/004758; registration (publication) number: to be determined |
| Impact on Business Performance | This matter will have no impact on full-year results for the fiscal year ending July 2026. |
| Reason | The purpose is to expand the indications for Redasemtide, which is currently under development. The granting of the patent will preserve the possibility of developing treatments for cartilage diseases based on Redasemtide in Mexico. |
| Future plans | The company will promptly disclose any matters requiring disclosure. |
| Title of invention | Treatment for cartilage diseases |
| Filing jurisdiction | Mexico |
| Applicant | StemRIM Inc.; Osaka University |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The purpose is to expand the indications for Redasemtide, which is currently under development, and the granting of the patent will preserve the possibility of developing treatments for cartilage diseases in Mexico.